PubRank

M M Hansen

Author PubWeight™ 48.98‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Extent and scale of local adaptation in salmonid fishes: review and meta-analysis. Heredity (Edinb) 2011 2.21
2 Post-prandial glucose excursions following four methods of bolus insulin administration in subjects with type 1 diabetes. Diabet Med 2002 1.63
3 Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors. J Med Chem 1999 1.46
4 The bone-marrow infiltration pattern in B-cell chronic lymphocytic leukemia is not an important prognostic factor. Danish CLL Study Group. Eur J Haematol 1996 1.45
5 Refractory myelomatosis treated with mitoxantrone in combination with vincristine and prednisone (NOP-regimen): a phase II study. The Nordic Myeloma Study Group (NMSG) Br J Haematol 1991 1.45
6 Male reproductive competition in spawning aggregations of cod (Gadus morhua, L.). Mol Ecol 2002 1.36
7 Xanthomonas maltophilia bacteremia in immunocompromised hematological patients. Scand J Infect Dis 1994 1.16
8 Risk of therapy-related leukaemia and preleukaemia after Hodgkin's disease. Relation to age, cumulative dose of alkylating agents, and time from chemotherapy. Lancet 1987 1.15
9 Fisheries. Population of origin of Atlantic cod. Nature 2001 1.13
10 An assessment of the spatial scale of local adaptation in brown trout (Salmo trutta L.): footprints of selection at microsatellite DNA loci. Heredity (Edinb) 2011 1.09
11 Genetic consequences of population decline in the European otter (Lutra lutra): an assessment of microsatellite DNA variation in Danish otters from 1883 to 1993. Proc Biol Sci 2001 1.07
12 Use of a methyl hydrazine derivative (natulan), especially in Hodgkin's disease. Acta Med Scand 1966 1.06
13 A randomized study of radiotherapy versus radiotherapy plus chemotherapy in stage I-II non-Hodgkin's lymphomas. Cancer 1983 1.02
14 Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin's lymphoma. N Engl J Med 1988 0.99
15 Genome-wide single-generation signatures of local selection in the panmictic European eel. Mol Ecol 2014 0.99
16 A resource of genome-wide single-nucleotide polymorphisms generated by RAD tag sequencing in the critically endangered European eel. Mol Ecol Resour 2013 0.95
17 In B-cell chronic lymphocytic leukaemia chromosome 17 abnormalities and not trisomy 12 are the single most important cytogenetic abnormalities for the prognosis: a cytogenetic and immunophenotypic study of 480 unselected newly diagnosed patients. Leuk Res 1998 0.93
18 Genetic introgression between wild and stocked salmonids and the prospects for using molecular markers in population rehabilitation: the case of the Adriatic grayling (Thymallus thymallus L. 1785). Heredity (Edinb) 2004 0.93
19 Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia. Blood 1991 0.91
20 Spatially and temporally fluctuating selection at non-MHC immune genes: evidence from TAP polymorphism in populations of brown trout (Salmo trutta, L.). Heredity (Edinb) 2007 0.88
21 Changing etiology of bacteremia in patients with hematological malignancies in Denmark. Scand J Infect Dis 1994 0.87
22 Distribution of individual inbreeding coefficients, relatedness and influence of stocking on native anadromous brown trout (Salmo trutta) population structure. Mol Ecol 2001 0.86
23 A prospective study of gentamicin ototoxicity. Acta Otolaryngol 1978 0.86
24 Social Media for the Promotion of Holistic Self-Participatory Care: An Evidence Based Approach. Contribution of the IMIA Social Media Working Group. Yearb Med Inform 2013 0.85
25 Differences in salinity tolerance and gene expression between two populations of Atlantic cod (Gadus morhua) in response to salinity stress. Biochem Genet 2011 0.85
26 Effects of stair-stepping exercise direction and cadence on EMG activity of selected lower extremity muscle groups. J Orthop Sports Phys Ther 1994 0.84
27 Nephrotoxicity in combined cephalothin and gentamicin therapy. Acta Med Scand 1977 0.84
28 Organic mercury in Greenland birds and mammals. Sci Total Environ 1990 0.83
29 Chronic lymphocytic leukaemia. Clinical studies based on 189 cases followed for a long time. Scand J Haematol Suppl 1973 0.83
30 Stocking impact and temporal stability of genetic composition in a brackish northern pike population (Esox lucius L.), assessed using microsatellite DNA analysis of historical and contemporary samples. Heredity (Edinb) 2005 0.82
31 Fatal hepatitis following irradiation and vincristine. Acta Med Scand 1982 0.82
32 Improved vaccination response during ranitidine treatment, and increased plasma histamine concentrations, in patients with B cell chronic lymphocytic leukemia. Leukemia 1995 0.81
33 The bone marrow histological pattern has independent prognostic value in early stage chronic lymphocytic leukaemia. Br J Haematol 1986 0.80
34 Multiple autoimmune manifestations in monoclonal gammopathy of undetermined significance and chronic lymphocytic leukemia. Leukemia 1996 0.80
35 Splenectomy in chronic lymphocytic leukaemia. Scand J Haematol 1977 0.80
36 B-cell chronic lymphocytic leukaemia: clonal chromosome abnormalities and prognosis in 89 cases. Eur J Haematol 1989 0.80
37 Nuclear clefts in chronic lymphocytic leukaemia. A light microscopic and ultrastructural study of a new prognostic parameter. Scand J Haematol 1983 0.79
38 Subcutaneous lesions and bacteraemia due to Stenotrophomonas maltophilia in three leukaemic patients with neutropenia. Br J Dermatol 1997 0.79
39 Aberrations of chromosome 6 in 193 newly diagnosed untreated cases of chronic lymphocytic leukemia. Cancer Genet Cytogenet 1991 0.79
40 Same-day versus staged anterior-posterior spinal surgery in a neuromuscular scoliosis population: the evaluation of medical complications. J Pediatr Orthop 1996 0.78
41 Treatment of hypogammaglobulinaemia in chronic lymphocytic leukaemia by low-dose intravenous gammaglobulin. Eur J Haematol 1994 0.78
42 Cefotaxime versus ampicillin, methicillin and netilmicin in combination for treatment of febrile episodes in patients with haematologic malignancy. Acta Med Scand 1983 0.78
43 Cytoplasmic inclusions in lymphocytes of chronic lymphocytic leukaemia. A report of 10 cases. Virchows Arch A Pathol Anat Histol 1982 0.77
44 Cell markers in lymphoproliferative disease. Lancet 1984 0.77
45 Oral cladribine as primary therapy for patients with B-cell chronic lymphocytic leukemia. J Clin Oncol 1996 0.77
46 Autoimmunity and extranodal lymphocytic infiltrates in lymphoproliferative disorders. J Intern Med 1999 0.77
47 Ovarian function in young women in long-term remission after treatment for Hodgkin's disease stage I or II. Scand J Haematol 1984 0.77
48 Long-term efficacy of humalog in subjects with Type 1 diabetes mellitus. Diabet Med 1999 0.77
49 Simultaneous presence of translocations t(14;18) and t(2;8) in a case of chronic lymphocytic leukemia. Cancer Genet Cytogenet 1986 0.77
50 Kin-biased distribution in brown trout: an effect of redd location or kin recognition? Heredity (Edinb) 2004 0.76
51 Adenomatoid tumours of the testis and epididymis. Scand J Urol Nephrol 1969 0.76
52 Chronic lymphocytic leukaemia: a test of a proposed new clinical staging system. Scand J Haematol 1981 0.76
53 Cefotaxime monotherapy in septicemic patients with hematological malignancies. Clin Ther 1986 0.75
54 [Medical treatment of cancer]. Ugeskr Laeger 1997 0.75
55 Salvage therapy with fludarabine in patients with progressive B-chronic lymphocytic leukemia. Leuk Lymphoma 1996 0.75
56 Mouse erythrocyte rosette formation with malignant human B-lymphocytes re-evaluated: still a useful marker for differentiating mature B-cell malignancies. Br J Haematol 1992 0.75
57 Comments on economic evaluation of chemotherapy. Pharmacoeconomics 1997 0.75
58 B cell chronic lymphocytic leukaemia: recent concepts in classification and treatment. Eur J Haematol Suppl 1988 0.75
59 Refractoriness to alpha-interferon (Intron A) in previously chemotherapy-treated patients with chronic myelocytic leukaemia. Eur J Haematol 1988 0.75
60 [Gentamicin and ototoxicity. A prospective study]. Ugeskr Laeger 1976 0.75
61 Pharmacoeconomic considerations in treating patients with acute leukaemia. Pharmacoeconomics 1999 0.75
62 High activity of mitoxantrone in previously untreated low-grade lymphomas. Cancer Chemother Pharmacol 1988 0.75
63 [A fundamentally new cytostatic: a methylhydrazine derivative (Natulan)]. Ugeskr Laeger 1966 0.75
64 [Medullary compression in systemic malignant diseases. The imperative importance of early therapy]. Ugeskr Laeger 1975 0.75
65 Multiple myeloma treated with mitoxantrone in combination with vincristine and prednisolone (NOP regimen) versus melphalan and prednisolone: a phase III study. Nordic Myeloma Study Group (NMSG). Eur J Haematol 1993 0.75
66 [Treatment of acute myeloblastic leukemia. Experiences with "conventional" single-drug therapy, 1968-70, and intensive combination chemotherapy, 1971-73]. Ugeskr Laeger 1975 0.75
67 [Hyperadrenocorticism (Cushing's syndrome) with malignant tumors in a "non-endocrine" organ]. Ugeskr Laeger 1965 0.75
68 The CLL2 study: preliminary results of flow cytometry immunophenotyping in the first 500 patients. Nouv Rev Fr Hematol 1988 0.75
69 Pharmacoeconomic aspects in the treatment of curable and incurable cancer. Pharmacoeconomics 1995 0.75
70 BEAM+autologous stem cell transplantation in malignant lymphoma: 100 consecutive transplants in a single centre. Efficacy, toxicity and engraftment in relation to stem-cell source and previous treatment. Eur J Haematol 1998 0.75
71 [Autologous stem cell transplantation. From bone marrow to selected blood stem cells: 100 consecutive procedures at a single center]. Ugeskr Laeger 1996 0.75
72 [Acute non-lymphocytic leukemia (ANLL) in adults. Therapeutic criteria and their consequences]. Ugeskr Laeger 1988 0.75
73 Lack of prognostic significance of T-lymphocyte subset counts in B-cell chronic lymphocytic leukaemia. Eur J Haematol 1987 0.75
74 [Occult hemolacrima in hematological patients. Study using a simple stix method]. Ugeskr Laeger 1980 0.75
75 The applicability of simple blood and bone marrow variables in prediction of acute leukaemia in patients with acquired bi- or pancytopenia. Scand J Haematol 1981 0.75
76 [Allogenic bone marrow transplantation in acute leukemia and non-Hodgkin's malignant lymphoma]. Ugeskr Laeger 1987 0.75
77 [Effects of immunoglobulin (Intraglobin) on tendency toward infection in chronic lymphatic leukemia]. Ugeskr Laeger 1987 0.75
78 [Prolymphocytic leukemia]. Ugeskr Laeger 1981 0.75
79 Preparing for high-level nursing administration positions. CCQ 1982 0.75
80 [Nephrotoxicity of combined therapy with cephalothin and gentamicin]. Ugeskr Laeger 1976 0.75
81 [Campath-1H--a monoclonal antibody for treatment of non-Hodgkin's and chronic lymphatic leukemia]. Ugeskr Laeger 1997 0.75
82 Preparing students to shape health policy. Nurs Outlook 1989 0.75
83 [Chronic lymphatic leukemia. A review of recent examination methods]. Ugeskr Laeger 1984 0.75
84 Diffuse lymphosarcomatous infiltration in the central nervous system. Scand J Haematol 1976 0.75
85 Synthesis and anticonvulsant activity of 3-aryl-5H-2,3-benzodiazephine AMPA antagonists. Bioorg Med Chem Lett 1999 0.75
86 [Total vagotomy and pyloroplasty by Weinberg's method as the operation of choice in 190 patients with duodenal ulcer]. Ugeskr Laeger 1971 0.75
87 [Chronic lymphocytic leukemia treated with herbal remedy consisting of plant extracts]. Ugeskr Laeger 1979 0.75
88 [Quality of cryopreserved ejaculate in Hodgkin disease]. Ugeskr Laeger 1995 0.75
89 GM-CSF treatment in patients with B-chronic lymphocytic leukemia. Leuk Lymphoma 1999 0.75
90 Netilmicin therapy of patients with leukaemia or malignant lymphoma. Scand J Infect Dis Suppl 1980 0.75
91 [Natulanar, Roche (Procarbazine)]. Ugeskr Laeger 1968 0.75
92 Chronic lymphocytic leukaemia of T cell origin. Clinical variation possibly due to involvement of different T lymphocyte subpopulations. Scand J Haematol 1983 0.75
93 [Clinical experiences with a methylhydrazine derivative (Natulan)]. Ugeskr Laeger 1966 0.75
94 [Treatment of primary low-malignant ventricular lymphomas by means of Helicobacter pylori eradication]. Ugeskr Laeger 1998 0.75
95 [Chronic lymphatic leukemia. Peroral cladribine as primary treatment]. Ugeskr Laeger 1996 0.75
96 VP-16-213 in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone in the treatment of non-Hodgkin's lymphomas. Cancer Treat Rep 1981 0.75
97 Testicular function in young men in long-term remission after treatment for the early stages of Hodgkin's disease. Scand J Haematol 1984 0.75
98 Accident or child abuse? Challenge to emergency nurses. J Emerg Nurs 1977 0.75
99 Clinical trial of prednimustine, Leo-1031 (NSC-134087), in patients with non-Hodgkin lymphomata and chronic lymphocytic leukaemia previously treated with steroids and alkylating agents. Acta Med Scand 1980 0.75
100 [Pseudothrombocytopenia induced by EDTA]. Ugeskr Laeger 1978 0.75
101 Effect of sodium nitroprusside on hypoxic pulmonary vasoconstriction in the dog. J Appl Physiol Respir Environ Exerc Physiol 1981 0.75